Translational Research and Discovery in Gastroenterology

Translational Gastroenterology: Organogenesis to Disease bridges the gap between basic and clinical research by providing information on GI (gastrointestinal) organ development discovered through scientific inquiry, alongside clinical observations of acquired and congenital abnormalities. Paired chapters, written from basic science and clinical viewpoints, review the major biological pathways and molecules at work in organ ontogeny and disease. In addition to a comprehensive survey of GI organ development and pathologies, the book also highlights model organisms and new areas of research, with chapters devoted to recent advances in the field of GI stem cell biology, and the potential for tissue engineering of GI organs. The topics covered provide a unique window onto current activity in the field of gastroenterology, fostering enhanced knowledge for developmental biologists as well as for clinical practitioners. Notable features include the following: • Basic science chapters review the molecular and cellular pathways of GI organ development alongside clinical chapters examining organ-based diseases, closing the gap between the bench and the clinic. • Derivative organs – esophagus, stomach, pylorus, small intestine, colon, liver, and pancreas –as well as tissues such as serosa and enteric nervous system that are common to multiple GI organs. • Chapters detailing the use of model organisms – Drosophila, sea urchin, zebrafish, C. elegans, Xenopus – for basic discovery studies are included. • Chapters on GI stem cells and the potential for tissue engineering of the GI organs provide a view to the future of research and therapy in these organs.

Produk Detail:

  • Author : Deborah L. Gumucio
  • Publisher : John Wiley & Sons
  • Pages : 352 pages
  • ISBN : 1118492870
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKTranslational Research and Discovery in Gastroenterology

Translational Research and Discovery in Gastroenterology

Translational Research and Discovery in Gastroenterology
  • Author : Deborah L. Gumucio,Linda C. Samuelson,Jason R. Spence
  • Publisher : John Wiley & Sons
  • Release : 11 August 2014
GET THIS BOOKTranslational Research and Discovery in Gastroenterology

Translational Gastroenterology: Organogenesis to Disease bridges the gap between basic and clinical research by providing information on GI (gastrointestinal) organ development discovered through scientific inquiry, alongside clinical observations of acquired and congenital abnormalities. Paired chapters, written from basic science and clinical viewpoints, review the major biological pathways and molecules at work in organ ontogeny and disease. In addition to a comprehensive survey of GI organ development and pathologies, the book also highlights model organisms and new areas of research, with

Evidence-based Gastroenterology and Hepatology

Evidence-based Gastroenterology and Hepatology
  • Author : John W. D. McDonald,Brian G. Feagan,Rajiv Jalan,Peter J. Kahrilas
  • Publisher : John Wiley & Sons
  • Release : 29 April 2019
GET THIS BOOKEvidence-based Gastroenterology and Hepatology

The revised fourth edition of Evidence-Based Gastroenterology and Hepatology continues to provide the most current, evidence-based information for determining the appropriate medical and surgical options for screening for, diagnosing, and treating gastrointestinal conditions. With contributions from an international team of leading experts in the field, the 4th edition includes practical recommendations for the care of individual patients based on the latest scientific evidence.

Global Clinical Trials Playbook

Global Clinical Trials Playbook
  • Author : Menghis Bairu,Richard Chin
  • Publisher : Academic Press
  • Release : 25 May 2022
GET THIS BOOKGlobal Clinical Trials Playbook

Pharmaceuticals companies, biotech companies, and CROs, regardless of size, all face the same challenge of managing costs and operational execution associated with bringing a valuable drugs and devices to market. Because of timeline pressures and cost as well as the growing interest in "neglected diseases" and diseases affecting the emerging nations, clinical trials are increasingly conducted in emerging markets and developing countries where infrastructure, leadership, skilled personnel and a governance are at a premium. Working with academics, regulatory professionals, safety

Contested Cells: Global Perspectives On The Stem Cell Debate

Contested Cells: Global Perspectives On The Stem Cell Debate
  • Author : Benjamin J Capps,Alastair V Campbell
  • Publisher : World Scientific
  • Release : 19 August 2010
GET THIS BOOKContested Cells: Global Perspectives On The Stem Cell Debate

This book represents the coming together of a number of internationally renowned scholars from science, philosophy, law and social science. Each author presents a distinctive and critical account of the current ethical, social and jurisprudential issues concerning stem cell science: together covering both its research beginnings, and the future translation into the clinical setting. Original to this volume is an emphasis on the inter-state implications of developments in stem cell science from the perspective of a truly global collaboration of

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease
  • Author : Andrew J. Krentz,Christian Weyer,Marcus Hompesch
  • Publisher : Springer
  • Release : 02 April 2019
GET THIS BOOKTranslational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease

This book aims to aid the selection of the most appropriate methods for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, non-alcoholic fatty liver disease (NAFLD) and related cardiometabolic disorders. Clinical research methods to assess the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycemic clamp technique, have become well-established in proof-of-mechanism studies. However, selection of the most appropriate techniques is by no means straightforward. Moreover, the application of such methods must conform

Malaysia & Bengali Doctors 1907-2012 a Personal Perspective

Malaysia & Bengali Doctors 1907-2012 a Personal Perspective
  • Author : Dr. P. R. Sengupta
  • Publisher : Xlibris Corporation
  • Release : 23 March 2013
GET THIS BOOKMalaysia & Bengali Doctors 1907-2012 a Personal Perspective

The past century has been an exciting era for the Bengalis in Malaysia attempting to preserve our identity and cultural heritage. However with the dilution of the community the radar for the coming years is misty. In the course of our efforts to uphold our identity and provide services to the public and be counted, we have not lost sight of our primary professional responsibility as doctors. Many have contributed towards the advancement of the profession by actively participating in

Evaluating and Conducting Research in Audiology

Evaluating and Conducting Research in Audiology
  • Author : Vinaya Manchaiah, Eldré Beukes, Ross J. Roeser
  • Publisher : Plural Publishing
  • Release : 04 February 2021
GET THIS BOOKEvaluating and Conducting Research in Audiology

Evaluating and Conducting Research in Audiology is the first research methods textbook that is specific to the field of audiology and designed to serve as an academic textbook for audiology graduate students. This text can also be accessible for audiology practitioners who are interested in clinical and applied research. The comprehensive coverage includes materials for multiple courses within audiology degree programs, including research methods, analysis of professional literature, evidence-based practice, and capstone research projects. Classroom tested, and written by authors

Resistance to Molecular Therapies for Hepatocellular Carcinoma

Resistance to Molecular Therapies for Hepatocellular Carcinoma
  • Author : Augusto Villanueva
  • Publisher : Springer
  • Release : 14 July 2017
GET THIS BOOKResistance to Molecular Therapies for Hepatocellular Carcinoma

This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other

Smith's Anesthesia for Infants and Children E-Book

Smith's Anesthesia for Infants and Children E-Book
  • Author : Peter J. Davis,Franklyn P. Cladis
  • Publisher : Elsevier Health Sciences
  • Release : 30 November 2021
GET THIS BOOKSmith's Anesthesia for Infants and Children E-Book

Written and edited by renowned experts in pediatric anesthesia, Smith's Anesthesia for Infants and Children provides clear, concise guidance on effective perioperative care for any type of pediatric surgery. The 10th Edition contains significantly revised content throughout, bringing you fully up to date with recent advances in clinical and basic science that have led to changes in today’s clinical practice. Offers comprehensive coverage of physiology, pharmacology, and clinical anesthetic management of infants and children of all ages. Contains new

New Insights in the Landscape of Rare Tumors: Translational and Clinical Research Perspective

New Insights in the Landscape of Rare Tumors: Translational and Clinical Research Perspective
  • Author : Toni Ibrahim,Jean-Yves Blay,Alberto Bongiovanni,Alessandro De Vita
  • Publisher : Frontiers Media SA
  • Release : 22 December 2020
GET THIS BOOKNew Insights in the Landscape of Rare Tumors: Translational and Clinical Research Perspective

TI has received honoraria from Eisai as a consultant and grants or funding to his institution from Novartis. TI participated in congress for which travel and accommodations were paid by Ipsen, Pharmamar, and Novartis.